IL6 and hepatocellular carcinoma: (2024) identified distinct immunophenotypes in HBV-positive HCC, including an increased expression of pro-inflammatory cytokines such as IL-6 and TNF-α, which could potentially sensitize tumors to immunotherapy (27).